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ABSTRACT 
Staphylococcus aureus is the most common and important cause of life threatening 
bacterial infection with a high mortality rate. The absence of a positive culture represents 
a dilemma in diagnosis and treatment, therefore an alternative method that is cheap, user 
friendly and rapid with high sensitivity and specificity is needed to help in the diagnosis. 
This study was done to identify the presence of antigenic and specific proteins of whole 
cell for Staphylococcus aureus, which can be used to develop a rapid serological test. By 
applying the technique of sodium dodecyl sulphate-polycarylamide gel electrophoresis 
(SDS-PAGE) and Western blotting, three proteins with molecular weight of 18 kDa, 21. 
5 kDa and 28 kDa were found to be antigenic and specific for methicillin-sensitive 
Staphylococcus aureus. These proteins were only specific to IgM antibodies but not to 
IgA and IgG antibodies. Two proteins were found to be antigenic and specific for 
methicillin-resistant Staphylococcus aureus. The proteins were 57 kDa protein which was 
specific to IgM antibody only and 40 kDa protein which was only specific to IgG 
antibody. 
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ABSTRAK 
Jangkitan Staphylococcus aureus sering berlaku dan memudaratkan manusia dengan 
kadar kematian yang tinggi. Dilema dalam diagnosis dan rawatan timbul sekiranya tiada 
organisma dapat dipencilkan., Oleh itu satu kaedah diagnosis lain yang murah, ringkas 
dan cepat dengan spesifisiti dan sensitiviti yang tinggi amat diperlukan. 
Kajian ini dilakukan untuk mengenalpasti kehadiran protin sel keseluruhan yang sensitif 
dan spesifik bagi Staphylococcus aureus yang boleh digunakan untuk membangunkan 
ujian serologi yang pantas. Dengan menggunakan kaedah elektroforesis gel natrium 
dodesil sulfat-poliakrilamida (SDS-PAGE) dan immunoassai blot Western, tiga protein 
yang mempunyai berat molekul 18 kDa, 21. 5 kDa and 28 kDa telah didapati bersifat 
antigenik dan spesifik bagi Staphylococcus aureus yang sensitif kepada metisilin. Protein 
ini hanya mepunyai tindakbalas dengan antibodi IgM sahaja dan tidak kepada antibodi 
IgA and IgG. Untuk Staphylococcus aureus yang rintang terhadap metisilin, dua protein 
yang antigenik dan spesifik telah dikenalpasti. Protein berberat 57 kDa bertindak balas 
secara spesifik kepada antibodi IgM sahaja dan protein berberat 40 kDa yang 
bertindakbalas secara spesifik kepada antibodi IgG sahaja. 
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1.1 Staphylococcus spp. 
1.1.1 History and taxonomy 
CHAPTER ONE 
INTRODUCTION 
Sir Alexander Ogston, a surgeon, was the first to describe staphylococcal disease 
and its role in sepsis and abscess formation, in 1880 and 1882 (Lowy, 1998). He 
had chosen the term Staphylococcus, derived from the Greek expression staphyle, 
which means bunch of grapes because of the characteristic microscopic 
arrangement in clusters. In 1884, Rosenbach described the two pigmented colony 
types of Staphylococcus aureus (yellow) and Staphylococcus a/bus (white). 
Staphylococcus a/bus is now known as Staphylococcus epidermidis. Until now, 
Staphylococcus aureus (S. aureus) remains a versatile and important pathogen in 
human. 
Taxonomically, the genus Staphylococcus is a member of the Micrococcaceae but 
phylogenetically it is unrelated to any other genera in the family. On the basis of 
16s RNA analysis, the genus Staphylococcus belongs to the broad Bacillus-
Lactobacillus-Streptococcus cluster. Staphylococcus can be further classified into 
three main species of clinical importance (i.e. S. aureus, S. epidermidis, and S. 
saprophyticus). The three species can be distinguished from each other by colony 
morphology and the following tests - catalase, coagulase, mannitol fermentation, 
the deoxyribonuclease test and novobiocin resistance tested by disk diffusion with 
a 5 J.lg novobiocin disk (Table 1.1 ). 
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Table 1.1 Major tests for the differentiation of human staphylococci 
Test S. aureus s. epidermidis S. saprophyticus 
Catalase + + + 
Coagulase + - -
Acid production by mannitol + - Usually positive 
fermentation Occasionally 
negative 
DNAse + - -
Hemolysis + Usually negative -
Occasionally 
positive 
Anaerobic growth + + -
Novobiocin sensitive sensitive resistance 
1.1.2 Morphology and physiology 
Microscopically, S. aureus is a gram positive organism characterized by 
individual cocci with a diameter of 1. 5 to 1. 7 J.tm. These cocci occurs singly, in 
pairs, or in short chains and have a strong tendency to form clusters because cell 
divisions occurs in three perpendicular planes which does not lead to full 
separation of the daughter cells. Cluster formation is favored by culturing the 
organism on solid media. These properties are sometimes missing in clinical 
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specimens and can lead to erroneous diagnoses. Clustering can also be very 
limited in liquid media. 
Macroscopically, individual colonies are sharply defined, smooth, opaque, and 
convex, cream-yellow to golden pigmentation with a diameter of I to 3 mm 
within 24 hours with beta-hemolytic properties. Pigment production can be 
enhanced by further incubation at room temperature and daylight for 24 to 48 
hours. Most strains of S. aureus produce hemolysis within 24 to 36 hours on 
horse, sheep, or human blood-agar plates. When encapsulated, the organisms 
appear as mucoid, sticky colonies. 
Staphylococci are non-motile and are facultative anaerob. S. aureus is extremely 
hardy and can survive drying, extremes of environmental temperature, wide 
ranges of pH and high salt. It can therefore survive in the hospital environment for 
some time and can be cultured from dried clinical material even after several 
months (Waldvegal, 2000). 
1.1.3 Important Staphylococcal components and products 
1.1.3.1 Cell wall 
Peptidoglycan is the basic component of the cell wall of S. aureus that 
confers shape and stability to the organism. It represents 50% of cell wall 
weight. It consists of alternating polysaccharide subunits of N-
acetylmuramic acid and N-acetylglucosamine with 1,4-P linkages. The 
peptidoglycan chains are cross-linked by tetrapeptide chains bound toN-
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acetylmuramic acid and by a pentaglycine bridge specific for S. aureus. 
The basic polysaccharide polymer is found in many other organisms as 
well, whereas the pentaglycine cross-linking chain is specific for S. aureus 
(Schleifer & Kandler, 1972). Peptidoglycan has endotoxin-like activity, it 
elicits the production of interleukin-1 from human monocytes, is capable 
of attracting polymorphonuclear leukocytes (PMNs ), activates 
complement, and elicits the production of opsonic antibodies (Kaplan et 
a/., 1982). Differences in the peptidoglycan structure of staphylococcal 
strains may contribute to variations in their capacity to cause disseminated 
intravascular coagulation (Kessler et a/., 1991) 
Another important cell wall components are the teichoic acids, which are 
polymers of glycerol or ribitol phosphate and they can be antigenic. 
Ribitol teichoic acid, which is covalently bound to peptidoglycan is the 
major constituents of the cell wall. Lipoteichoic acid is a glycerol 
phosphate polymer linked to the lipid of the bacterial cell membrane. 
Most staphylococci produce microcapsule or a loosely associated slime 
layer. 11 types of microcapsular polysaccharide serotypes have been 
identified and types 5 and 8 account for 75 percent of human infections. 
Most methicillin-resistant S. aureus isolates are type 5. This 
polysaccharide can be released during focal infection and be detected in 
the serum of infected animals (Arbeit & Dunn, 1987). 
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S. aureus has many surface proteins including major adhesins such as 
laminin, fibronectin-binding proteins and clumping factor (Hawiger et a/., 
1982) to promote attachment to host protein. An adhesin that promote 
attachment to collagen has been found in strains that cause osteomyelitis 
and septic arthritis (Patti eta/., 1994a). Interaction with collagen may also 
be important in promoting bacterial attachment to damaged tissue where 
the underlying layers have been exposed. Several of these related proteins 
bind extracellular-matrix molecules and have been designated microbial-
surface components recogmztng adhesive matrix molecules 
(MSCRAMM). Recent studies suggest that these proteins play an 
important part in the ability of staphylococci to colonize host tissue (Patti 
eta/., 1994b). 
Protein A is present in various amounts in most strains of S. aureus. It has 
antiphagocytic properties based on its ability to bind to the Fe terminal of 
all human IgG subclasses except lgG3 and can also activates complement. 
1.1.3.2 Enzymes 
Staphylococci produce vanous enzymes and toxins that have been 
implicated in the pathogenesis of the disease, however their specific 
effects are often disputed because it is difficult to purify them because of 
instability. 
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Protease, lipase and hyaluronidase are enzymes that can destroy tissue. 
These bacterial products may facilitate the spread of infection to adjoining 
tissues, although their role in the pathogenesis is not well defined. 
Hydrogen peroxide is produced by all staphylococcal strains and is 
converted into nontoxic H20 and 02 by the action of catalase. Because 
staphylococcal phagocytic killing is mediated by toxic oxygen radicals 
produced by PMNs, it has been proposed and shown that catalase 
production, by counteracting host defense mechanisms, correlates with 
pathogenicity (Mandell, 1975). 
Coagulase is a prothrombin activator, converts fibrinogen to fibrin The 
reaction is used to differentiate S. aureus from coagulase-negative 
staphylococci. Its contribution to bacterial virulence is uncertain. 
S. aureus forms clumps when mixed with plasma through an interaction 
between fibrinogen and a bacterial cell surface compound called clumping 
factor (Hawiger et al., 1982). This receptor is also responsible for the 
adherence of S. aureus to fibrinogen and fibrin. 
Beta-Iactamase is an enzyme that inactivates penicillin. Penicillin-binding 
proteins are enzymes located in the cytoplasmic membrane that are 
involved in cell-wall assembly. A novel penicillin-binding protein is 
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responsible for staphylococcal resistance to the penicillinase-resistant 
penicillin and cephalosporin. 
1.1.3.3 Toxins 
S. aureus produces numerous toxins. Some of them express their 
detrimental effect by enzymatic action and others such as toxic shock 
syndrome toxin and enterotoxins are potent cytokines inducer that act as 
superantigen. 
There are five membrane-damaging toxins produced by S. aureus - a-
toxin, P-toxin, ()-toxin, r-toxin and leukocidin. a-toxin is the most potent 
membrane-damaging toxin. Susceptible cells have a specific receptor for 
a-toxin, which allows the toxin to bind causing small pores. After 
binding, a complex series of secondary reaction occurs causing release of 
cytokines and trigger the production of inflammatory mediators. The 
consequent cellular damage may contribute to manifestations of the 
sepsis syndrome. P-toxin produces its cytotoxic effect on sphingomyelin 
and therefore active on variety of cells including human erythrocytes, 
leukocytes and fibroblast. The majority of human isolates of S. aureus do 
not express P-toxin. r-toxin lyses erythrocytes by unknown mechanism 
and o-toxin disrupts biologic membrane by a detergent-like action. 
Panton-Valentine leukocidin, is a leukocytolytic toxin that has been 
epidemiologically associated with severe cutaneous infection. It consists 
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of two components, which act together to damage membrane by forming 
pores, which leads to increased permeability to cations. 
The exfoliative toxins, including epidermolytic toxins A and B, causes 
skin erythema and separation as seen in scalded skin syndrome. Recent 
data suggest that these toxins are serine proteases and act as superantigen 
(Marrack & Kappler, 1990). 
Toxic shock syndrome toxin-1 (TSST -1 ), a pyrogenic exotoxin, is the 
cause of toxic shock syndrome (TSS) which is characterized by fever, 
desquamative skin rash, hypotension and multisystem involvement. It is 
structurally similar to Enterotoxin B and C. The gene for toxic shock 
syndrome toxin 1 is found in 20 percent of S. aureus isolates. 
About half of all strains of S. aureus isolated produce enterotoxins (A to 
E, G and H) (Archer, 2000). These heat-stable toxins are major causes of 
food poisoning and increase intestinal peristalsis, possibly by 
sympathetic activation. A central nervous system effect is also suggested 
by the intensity of vomiting in food poisoning. When expressed 
systematically, enterotoxins can also cause toxic shock syndrome. In 
fact, enterotoxin B and C cause 50% of non-menstrual cases of TSS. 
TSST -1, enterotoxins, and exfoliative toxins belong to the family of 
superantigens, which are molecules that share the characteristics: they 
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bind with high affinity to major histocompatibility complex class II 
receptors of monocyte-macrophages at sites distinct from the classic 
antigen-binding groove (Kim et al., 1994 ). This complex is recognized by 
the variable V ~ region of the T -cell receptor of some subsets of T 
lymphocytes, and superantigen-receptor interaction causes prolific 
activation or, under certain circumstances, inhibition of T -cell functions, 
including liberation of interleukin-1, tissue necrosis factor and interferon-
gamma (Marrack et a/., 1990). Small foci of superantigen-producing S. 
aureus, at a concentration of 10-13 to 10-14 mol/1, can lead to dramatic 
cytokine liberation which lead to major systemic effects such as fever, 
hypotension, skin lesions, shock, multiorgan failure and death. 
1.1.4 Antibiotic susceptibility 
Shortly after penicillin G became available, Spink and Ferris in 1945 reported the 
isolation of a resistant S. aureus strain that produced a beta-lactamase, a serine 
protease (penicillinase) that inactivated the antibiotic (Waldvegal, 2000). It 
rapidly spread to many S. aureus isolates and stimulated the development of 
semisynthetic penicillinase-resistant compounds; methicillin, the isoxazolyl 
penicillins (oxacillin, cloxacillin, etc.), and nafcillin between 1960 and 1964. 
They solved the resistance problem only temporarily. Isolation of methicillin-
resistant strains was reported in 1961 by Barber (Waldvegal, 2000). 
Methicillin resistance or intrinsic resistance has created maJor therapeutic, 
management, and epidemiologic problems throughout the world. This high level 
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of resistance requires the presence of the mecA gene that encodes penicillin-
binding protein (PBP) 2a. PBP 2a has low affinity for all beta-Iactams, 
conferring resistance not only to methicillin and other penicillin but also 
cephalosporin and carbepenams. The mecA genes probably originated from a 
different species of staphylococci. Although many methicillin-resistant strains 
appear to be descendants of a limited number of clones, some appear to be 
monoclonal in origin, suggesting the horizontal transfer. The expression of 
resistance to methicillin is often heterogenous, and the percentage of a bacterial 
population that expresses the resistance phenotype varies according to the 
environmental conditions. The mecA gene, which has been cloned and 
sequenced, can be detected by DNA probes or by polymerase chain reaction 
(PCR). 
Methicillin resistance is defined as an oxacillin MIC of 4 mg/liter or greater or a 
methicillin MIC of 16 mglliter or greater. Several methods are available to 
detect methicillin resistance, which is improved by supplementing the media 
with sodium chloride, a low temperature of 30°C, and a high inoculum. When 
disk diffusion is used, an oxacillin disk charged with 1 J.lg should be applied to 
Mueller-Hinton agar containing 5% sodium chloride and incubated at 37°C or 
without sodium chloride and incubated at 30°C with an inoculum of 106 cfu/ml. 
MRSA frequently is cross resistant to aminoglycosides, lincosamides, 
macrolides, tetracyclines, trimethoprim and sulfonamides. Aminoglycoside-
resistant strains have been described with increasing frequency however the 
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percentage seems to be lower for fusidic acid. Rifampin, which is remarkably 
active against S. aureus, cannot be used as a single agent because of a high one-
step mutation rate of 1 o-7 to 1 o-s to resistance. Resistance to fluoroquinolones 
has been found in methicillin-sensitive (Kaatz et a/., 1991) and methicillin-
resistant strains (Murakami & Tomasz, 1989) and is becoming a major 
epidemiologic problem. 
Now, a new threat has emerged: the first case of vancomycin-intermediateS. 
aureus (VISA) was reported in 1996 from Japan (Hiramatsu et al., 1997) 
followed by various other strains in the United States, and several other 
countries. The mechanism of resistance in these isolates is not known but is not 
due to van resistance genes present in vancomycin-resistant enterococci. The 
suggested mechanisms are increased cell-wall synthesis and alterations in the 
cell wall that prevent vancomycin from reaching sites of cell-wall synthesis. 
The emergence of intermediately vancomycin-resistant S. aureus has created 
considerable concern in the medical community and are likely to pose a major 
therapeutic challenge in the future. 
1.1.5 Epidemiology 
J.J.5.1Colonization and Infection 
Humans are natural reservoir of S. aureus. Shortly after birth, many 
neonates are colonized by S. aureus by their immediate human 
surroundings either on the skin, the umbilical stump, the perineal area 
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and sometimes the gastrointestinal tract. Later on most children and 
adults will become intermittently colonized by S. aureus and harbor the 
organism either in their nasopharynx or occasionally on their skin and 
clothing, rarely in the vagina (an important prerequisite in toxic shock 
syndrome), or exceptionally in the rectum or perineal area. Thirty to 50 
percent of healthy adults are colonized, with 10 - 20 percent persistently 
colonized (Casewell & Hill, 1986). Both methicillin-sensitive and 
methicillin-resistant isolates are persistent colonizers. In a recent study 
done in the community of New York City, the prevalence of S. aureus 
nasal carriage was 35% in children and 28% for guardians. (Shopsin et 
a/., 2000) 
Some groups of population are more prone to colonization with S. 
aureus. For example higher percentage of carriers are found in 
physicians, nurses and hospital ward attendants compared to general 
population. Rates of staphylococcal colonization are also high among 
patients with Type 1 diabetes, intravenous drug users, patients 
undergoing hemodialysis, patients with acquired immunodeficiency 
syndrome (Archer, 2000) and in surgical patients (Kluytmans et al., 
1995). 
Persons colonized with S. aureus are at risk for subsequent infections 
(Wenzel & Perl, 1995). The mucous membranes and the skin offer a very 
efficient mechanical barrier against local tissue invasion. If this barrier is 
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breached by trauma or surgery, ~: aureus may gain access to the 
underlying tissue and create a characteristic local abscess lesion. Toxin 
liberation to skin and other organs can cause various types of skin rash 
and general symptoms. At any time, multiplying bacteria can overcome 
local phagocytic mechanisms and gain access to the lymphatic channels 
and the blood stream. The ensuing staphylococcal bacteremia is a 
dreaded complication, and it can lead to metastatic infections (e.g., 
endocarditis, pneumonia, or osteomyelitis) and to the patient's demise. 
:MRSA strains are usually introduced into an institution by an infected or 
colonized patient (nasopharynx, tracheostomy site, wound) or by a 
colonized health care worker. Transfer from one patient to another via 
the colonized hands of health personnel or the inanimate environment 
(Mulligan et a/., 1993) has led to major epidemics in tertiary care 
hospitals, as well as in chronic care facilities. Risk factors for the 
acquisition of :MRSA include the administration of multiple antibiotics. 
Colonization of the anterior nares by MRSA carries a significantly 
greater risk for infection than does colonization by sensitive strains 
(Muder et al., 1991 ). Thus, epidemiologic surveys and control measures 
are particularly important regarding MRSA. 
1.1.5.2 Transmission 
Persons colonized with S. aureus strains are at increased risk of 
becoming infected with these strains. From the anterior nares, carriers 
transfer the organisms to their skin. Trauma provides a portal of entry for 
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the organtsm, wtth subsequent local and possibly generalized infection. 
In case of infection, the organism is often of endogenous origin, whereas 
in other cases, it is transmitted by hospital personnel or a family member. 
Most cases of nosocomial infection are acquired through exposure to the 
hands of health care worker after they have been transiently colonized 
with staphylococci from their own reservoir or from contact with an 
infected patient. 
1.1.5.3 Temporal trends inS. aureus disease 
The numbers of both community acquired and hospital-acquired 
infections have increased in the past 20 years. This trend parallels the 
increased use of intravascular devices. During the period from 1992 
through 1997, S. aureus was the most common cause of nosocomial 
cases of pneumonia and the third most common cause (after coagulase-
negative staphylococci and enterococci) of nosocomial bloodstream 
infections according to data from the National Nosocomial Infections 
Surveillance system of the Centers For Disease Control and Prevention 
(Richards et al., 1999). In St. Thomas' Hospital, United Kingdom, S. 
aureus accounted for 11% of bacteremic organisms from year 1986 to 
1995 (Edgeworth et al., 1999). 
A second trend is the worldwide increased of infections caused by 
methicillin-resistantS. aureus (MRSA) (Panlilio eta/., 1992). MRSA 
are also increasingly found in the community (Moreno et al., 1995) Data 
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trom the National Nosocomial Infections Surveillance system of USA 
from the period 1987 to 1997 show the number of methicillin-resistant S. 
aureus infections in intensive care units has continued to increase. A 
study on the susceptibility pattern of S. aureus isolated in Malaysian 
hospital showed that 40% of S. aureus are methicillin-resistant (Rohani 
et al., 1999). Methicillin-resistant strains have also become resistant to 
other antimicrobial agents (Speller et a/., 1997). The same 1 Q .. year CDC 
survey showed proportion of methicillin-resistant isolates with 
sensitivity only to vancomycin increased from 22.8 percent in 1987 to 
56.2 percents in 1997. 
1.1.6 Pathogenesis 
The disease syndromes caused by S. aureus can be divided into two different 
mechanisms. The organisms can become locally or systematically invasive by 
producing a variety of components that can thwart host defence mechanisms, or 
it can elaborate toxins that cause disease without the need for the organism itself 
to invade tissue. 
Colonization by S. aureus requires initial adherence to host cells. Adherence to 
nasal mucosal cells is mediated by the teichoic acid component of S. aureus and 
by a variety of other cell-associated ligands on S. aureus It is increased in 
chronic staphylococcal carriers and after vaccination or infection with influenza 
A (Davidson & Sanford, 1982). S. aureus binding to mucin may also be critical 
for colonization of the nasopharyngeal mucosa (Shuter eta/., 1996). 
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The factors that result in initial S. aureus infections are not clear, normal 
individuals seem to be fairly resistant to local infection. Intact cornified 
squamous epithelium is normally a barrier both to colonization and infection by 
S. aureus. 
Infections are initiated when a breach of the skin or mucosal barrier allows 
staphylococci access to adjoining tissues or the bloodstream. Whether an 
infection is contained or spreads depends on a complex interplay between 
S.aureus virulence determinants and host defense mechanisms. 
Patients with certain congenital defects are predisposed to S. aureus infection. 
These includes chemotaxis defects as in Job's syndrome, Chediak-Higashi 
syndrome and Wiskott-Aldrich syndrome, opsonization defects, staphylocidal 
defects of polymorphonuclear leukocytes (Waldvegal, 2000). 
The risk of infection is also increased by the presence of foreign material. Elek 
and Conen first demonstrated the ability of sutures to reduce the threshold for 
infection (Walgvegal, 2000). Several factors contribute to the increased 
susceptibility to infection. Phagocytic function in the presence of foreign 
material is seriously impaired. Devices such as intravenous catheters are rapidly 
coated with serum constituents, such as fibrinogen or fibronectin, which enable 
staphylococci to adhere through MSCRAMM-mediated mechanisms and to 
elaborate glycocalices that further facilitate colonization. Intravenous catheters 
are frequently implicated in the pathogenesis of nosocomial endocarditis. The 
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Introduction of long-term indwelling catheters has led to cases of nosocomial 
endocarditis. The catheter traumatizes the valvular surface, creating a 
nonbacterial thrombus on the cardiac valve that facilitates subsequent bacterial 
adherence. 
1.1. 6.1 Local infection 
The hallmark of localized staphylococcal infection is an abscess. An 
abscess consists · of central necrosis and liquefaction and containing 
cellular debris and multiplying bacteria surrounded by a layer of fibrin 
and intact phagocytic cells. The abscess may be superficial, in skin 
(furuncle), or deep, in organs (renal carbuncle) as a result of bacteremic 
dissemination. 
1.1.6.2 Invasive infections 
A small percentage of local infections progress to dissemination, where 
S. aureus gains access to the blood. Staphylococcal bacteremia may be 
complicated by endocarditis, metastatic infection, or the sepsis 
syndrome. The endothelial cell is central to these pathogenic processes. 
Staphylococci avidly adhere to endothelial cells and bind through 
adhesin-receptor interactions. In vitro studies demonstrate that after 
adherence, staphylococci are phagocytized by endothelial cells. The 
intracellular environment protects staphylococci from host defense 
mechanisms as well as the bactericidal effects of antibiotics. These 
factors may enhance bacterial survival and contribute to the development 
of persistent or recurrent infections. 
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Staphylococcal strains that cause endocarditis adhere to both damaged 
and undamaged native valvular surfaces, are resistant to platelet 
microbicidal proteins and elaborate proteolytic enzymes that facilitate 
spread to adjacent tissues. The adherence of staphylococci to the platelet-
fibrin thrombus that forms on damaged valvular surfaces may involve 
the adherence MSCRAMM proteins to exposed matrix molecules. 
Staphylococcal endocarditis also occurs on undamaged valves. The 
invasion of endothelial cells by S.aureus may initiate the cellular 
alterations, including the expression of tissue factor, that promote the 
formation of vegetations. 
The cellular events leading to septic shock are similar in staphylococcal 
infection and infection with gram-negative bacteria. In both cases, 
monocytes and macrophages have a central role, although 
polymorphonuclear leukocytes, endothelial cells, and platelets also play 
a part. The monocytes release tumor necrosis factor-a and interleukin-1, 
interleukin-6, and interleukin-8 after contact with intact staphylococci, 
peptidoglycan, or lipoteichoic acid. In contrast, the expression of 
interleukin-1 and interleukin-6 by endothelial cells requires bacterial 
phagocytosis. As a result of cytokine and cellular activation, the 
complement and coagulation pathways are activated, arachidonic acid is 
metabolized, and platelet-activating factor is released. These events, in 
turn, cause fever, hypotension, capillary leak, disseminated intravascular 
coagulopathy, depression of myocardial function, and multiorgan 
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dysfunction. Several staphylococcal components appear to be capable of 
initiating the sepsis syndrome. Peptidoglycan, especially when combined 
with lipoteichoic acid, reproduces many of the physiologic responses of 
endotoxin in animal models of sepsis. Alpha toxin alone reproduces 
many of the findings of sepsis, including hypotension, 
thrombocytopenia, and reduce oxygenation, in animal models. 
1.1. 6. 3 Toxin-mediated disease 
S. aureus produces toxins, that produce specific syndromes without the 
need for the organism itself to invade and disseminate. Enterotoxins, 
exfoliative toxin and toxic shock syndrome toxin (TSST -1) have 
superantigen activity. Superantigens stimulate T cells non-specifically 
without normal antigenic recognition. Up to one in five T cells may be 
activated, whereas only 1 in 10,000 are stimulated during a usual antigen 
presentation. Cytokines are released in large amounts, causing the 
symptoms of TSS. Superantigens bind directly to class II major 
histocompatibility complexes of antigen-presenting cells outside the 
conventional antigen-binding groove. This complex recognizes only the 
V p element of the T cell receptor. Thus any T cell with the appropriate 
V p element can be stimulated, whereas normally antigen specificity is 
also required in binding. 
Enterotoxins cause diarrhea and vomiting when ingested and are 
responsible for staphylococcal food poisoning. TSST -1 is expressed 
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systemicaHy and is the cause of toxic shock syndrome (TSS ). When 
expressed systemically, enterotoxins can also cause toxic shock 
syndrome. TSS can occur as a sequel to any staphylococcal infection if 
an enterotoxin or TSST-1 is released systemically and the host lacks 
appropriate neutralizing antibodies. 
Exfoliatin toxin (ET) causes the scalded skin syndrome in neonates, 
which results in widespread blistering and loss of the epidermis. There 
are two antigenically distinct forms of the toxin, ETA and ETB. The 
toxins have a specific esterase activity, but it is not clear how this would 
causes epidermal splitting. There is some evidence that the toxins have 
protease activity, so it is also possible that the toxins target a very 
specific protein, which is involved in maintaining the integrity of the 
epidermis. 
1.1.6.4 Host response to infection 
The typical pathological finding of staphylococcal disease is abscess 
formation. Leukocytes are the primary host defense against S. aureus 
infection (Verdrengh & Tarkowski, 1997). The migration of leukocytes 
to the sites of infection results from the expression of adhesion 
molecules on endothelial cells. This cytokines mediated process is 
triggered by bacteria and tissue-based macrophages. After infection, 
cytokines are first demonstrable within vessels, extending into tissues as 
inflammatory cells migrate to the sites of infection. 
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The presence of opsonizing antibody directed against capsule, 
peptidoglycan, or complement facilitates phagocytosis in vitro (Peterson 
eta/., 1978; Karakawa eta/., 1988). The role of antibody in vivo is less 
certain, since the titer of antistaphylococcal antibodies is not correlated 
with protection from infection, except in which the presence of anti-toxic 
shock syndrome toxin-1 is protective (Freedman & Beer, 1991 ). 
IgG antibody response has been reported (Wheat, et al., 1978). High 
levels of IgG antibody were present in 70% - 90% of patients with 
staphylococcal endocarditis or bacteremia complicated by secondary 
sites of infection but not in patients with uncomplicated staphylococcal 
bacteremia. To study the IgM response to staphylococcal infections, 
Wheat et a/. in 1981 used solid-phase radioimmunoassay on ultrasonic 
extract of the Wood 46 strain of S. aureus. High levels of IgM were less 
frequent than high levels of IgG antibodies in patients with 
staphylococcal infection and both IgG and IgM were present in healthy 
control subjects but at lower levels than in infected patients. 
Concomitant elevations of levels of IgM and IgG antibodies to 
staphylococci was highly suggestive of staphylococcal endocarditis or 
complicated bacteremia. 
1.1. 7 Clinical and pathological features 
S. aureus causes a variety of suppurative (pus-forming) infections and toxinoses 
in humans. The infection can either be trivial, superficial, localized skin 
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infections such as folliculitis, stye and furuncles (boils) or more serious 
infections, such as pneumonia, mastitis, phlebitis, meningitis, urinary tract 
infection, and deep-seated infections such as osteomyelitis and endocarditis. 
S.aureus is a major cause of hospital-acquired infection of surgical wounds and 
infections associated with indwelling medical devices. S. aureus causes food 
poisoning by releasing enterotoxins into food, and toxic shock syndrome by 
release of pyrogenic extoxins into the blood stream. 
1.1. 7.1 Skin and soft tissue infections 
The most common S. aureus infections are folliculitis and the furuncle, 
or boil. These infections involve a single hair follicle or a localized area 
of the epidermis and dermis. Furuncles can coalesce and spread causing 
a more extensive and serious infection called carbuncle. Carbuncles are 
most common over the upper back and back of the neck, where they can 
form multiple draining sinuses; bacteremia occurs in approximately one 
fourth of patients. A boil or furuncle also may be called a skin abscess if 
it becomes large but remains circumscribed, confined to one area, and 
fluctuant. S. aureus can also cause cellulitis, particularly common in 
individuals with pre-existing chronic skin disease such as stasis 
dermatitis and diabetic, trophic, or decubitus ulcers. 
Impetigo is a very superficial staphylococcal skin infection that affects 
mostly children, usually on exposed areas of the body (e.g., on the face 
and the legs). Although most of these infections are due to S. aureus, 
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about 1 Oo/o are due to Streptococcus pyogenes and another I 0% wiH 
yield both organisms on culture 
The most common nosocomial S. aureus skin and soft tissue infection is 
the wound infection, in which surgical or catheter exit-site wounds are 
contaminated with S. aureus and become erythematous, draining 
purulent or serosanguineous fluid. S. aureus is the most common and 
most serious cause of hospital-acquired wound infections, leading to 
local, deep-wound infections and systemic, metastatic infections due to 
bacteremia. 
1.1. 7.2 Respiratory infections 
S. aureus is not a common cause of pneumonia tn healthy, 
unhospitalized adults, accounting for less than 10% of community-
acquired pneumonia. However, following influenza A infections, the 
incidence of S. aureus pneumonia markedly increases. Chest radiographs 
of patients with community-acquired S. aureus pneumonia may show 
abscesses and thin-walled cysts, resembling the pneumatoceles seen in 
infants. 
In contrast to community-acquired pneumonia, S. aureus is a prominent 
cause of nosocomial pneumonia, particularly in intubated patients on 
mechanical ventilation. Cultures obtained from intubated patients by 
techniques designed to minimize contamination of specimens by 
organisms colonizing the upper airway have found S. aureus in up to a 
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third of patients. Pneumonia in ventilator-dependent patients ts a 
particularly lethal event, with one fourth to one half of the patients dying 
as a direct result of their pulmonary infection. The radiographic 
appearance of nosocomial S. aureus pneumonia cannot be differentiated 
from that of pneumonia due to other nosocomial pathogens. 
1.1. 7. 3 Bacteremia 
The most common life-threatening manifestation of S aureus infection is 
bacteremia. A substantial proportion of S. aureus bacteremia appears to 
be of endogenous origin since they originate from colonies in the nasal 
mucosa (Von Eiff eta/., 2001). 
An increasing percentage of bacteremic infections are related to 
catheterization. In about one third of cases of septicemia, no initial focus 
of infection could be detected. The consequences of of nosocomial 
infection are usually fever and malaise, but they can include 
endocarditis, osteomyelitis, metastatic abscesses in various organs, and 
death from overwhelming sepsis. 
Use of injecting drugs is another contributing factor to the increased 
incidence of S aureus bacteremia. Users of injecting drugs often have 
nasal colonization with S aureus and likely transmit the organism to the 
skin, and eventually to the bloodstream, following unsterile injection 
practices. In users of injecting drugs, S aureus bacteremia is often 
accompanied by tricuspid valve endocarditis. 
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